PIK3CA and tumor of uterus: Targeted sequencing in primary uterine tumor revealed an activating PIK3CA hotspot exon 2 mutation (c.263G>A) with an allelic ratio of 27% and a KRAS exon 2 hotspot mutation (c.34G>A) with an allelic ratio of 51%.